Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,750 | 2 | 74.5% |
| Food and Beverage | $1,351 | 63 | 21.2% |
| Travel and Lodging | $182.69 | 1 | 2.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $60.76 | 2 | 1.0% |
| Education | $32.61 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $4,933 | 3 | $0 (2024) |
| ABBVIE INC. | $421.08 | 12 | $0 (2024) |
| PFIZER INC. | $365.83 | 17 | $0 (2024) |
| Celgene Corporation | $267.86 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $90.52 | 4 | $0 (2023) |
| FUJIFILM Medical Systems USA, Inc. | $60.76 | 2 | $0 (2018) |
| AIMMUNE THERAPEUTICS, INC. | $56.75 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $47.33 | 2 | $0 (2024) |
| GENZYME CORPORATION | $26.27 | 1 | $0 (2024) |
| Madrigal Pharmaceuticals | $24.57 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,344 | 20 | Eli Lilly and Company ($4,933) |
| 2023 | $593.06 | 33 | PFIZER INC. ($222.85) |
| 2022 | $193.63 | 11 | Celgene Corporation ($66.49) |
| 2021 | $67.32 | 3 | AbbVie Inc. ($50.93) |
| 2019 | $118.36 | 1 | AbbVie, Inc. ($118.36) |
| 2018 | $60.76 | 2 | FUJIFILM Medical Systems USA, Inc. ($60.76) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Eli Lilly and Company | OMVOH (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Eli Lilly and Company | OMVOH (Drug) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Immunology | ||||||
| 11/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: LIVER DISEASE | ||||||
| 11/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $182.69 | General |
| 10/30/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $31.27 | General |
| Category: GI | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: GI | ||||||
| 09/25/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $34.55 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.05 | General |
| Category: Neuroscience | ||||||
| 07/25/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: Neuroscience | ||||||
| 06/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $32.69 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/21/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/01/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2023 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 11/22/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: Neuroscience | ||||||
| 10/31/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $1.10 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 486 | 531 | $496,730 | $68,540 |
| 2022 | 11 | 551 | 573 | $452,586 | $65,417 |
| 2021 | 11 | 636 | 664 | $417,301 | $61,296 |
| 2020 | 11 | 403 | 443 | $295,174 | $43,525 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 135 | 135 | $202,186 | $17,348 | 8.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 69 | 69 | $98,394 | $15,651 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 111 | $38,628 | $11,543 | 29.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 33 | 33 | $35,674 | $6,431 | 18.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 56 | 57 | $66,924 | $4,812 | 7.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $16,260 | $4,003 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 40 | $9,480 | $2,885 | 30.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $15,617 | $2,733 | 17.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $10,382 | $2,320 | 22.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $3,185 | $813.51 | 25.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 142 | 142 | $190,706 | $17,902 | 9.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 58 | 58 | $82,708 | $12,749 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 104 | $36,192 | $10,520 | 29.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 31 | 31 | $32,798 | $6,191 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 55 | $13,035 | $3,986 | 30.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 47 | 47 | $52,828 | $3,776 | 7.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $15,176 | $3,532 | 23.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 44 | 51 | $15,300 | $3,097 | 20.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $9,308 | $2,420 | 26.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 14 | 14 | $3,430 | $784.90 | 22.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 17 | 17 | $1,105 | $460.72 | 41.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 64 | 64 | $95,074 | $14,251 | 15.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 114 | 115 | $154,003 | $13,049 | 8.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 69 | $23,499 | $7,491 | 31.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 55 | 55 | $27,872 | $6,563 | 23.5% |
About Dr. Crystal Bernstein, M.D
Dr. Crystal Bernstein, M.D is a Gastroenterology healthcare provider based in Edmonds, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326019167.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Crystal Bernstein, M.D has received a total of $6,377 in payments from pharmaceutical and medical device companies, with $5,344 received in 2024. These payments were reported across 70 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($4,750).
As a Medicare-enrolled provider, Bernstein has provided services to 2,076 Medicare beneficiaries, totaling 2,211 services with total Medicare billing of $238,778. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Edmonds, WA
- Active Since 01/30/2006
- Last Updated 01/20/2026
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1326019167
Products in Payments
- OMVOH (Drug) $4,750
- XELJANZ (Drug) $317.43
- ZEPOSIA (Drug) $267.86
- RINVOQ (Biological) $183.13
- STELARA (Biological) $90.52
- HUMIRA (Biological) $73.37
- ESD - Core Endoscopy (Device) $60.76
- VOWST (Biological) $56.75
- VELSIPITY (Drug) $48.40
- XIFAXAN (Drug) $47.33
- DUPIXENT (Biological) $26.27
- RESMETIROM (Drug) $24.57
- VIBERZI (Drug) $24.17
- LINZESS (Drug) $22.05
- VOQUEZNA (Drug) $19.24
- YUFLYMA (Biological) $17.26
- CIMZIA (Drug) $16.39
- ENTYVIO (Biological) $15.35
- OCALIVA (Drug) $15.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Edmonds
Klaus Mergener, M.d, M.D
Gastroenterology — Payments: $184,765
Jinfeng Guo, Md, MD
Gastroenterology — Payments: $8,702
Jason Schneier, Md, MD
Gastroenterology — Payments: $5,057
Dr. David Liang, M.d, M.D
Gastroenterology — Payments: $2,908
Sally Condon, Md, MD
Gastroenterology — Payments: $2,346
Gary Dines, Md, MD
Gastroenterology — Payments: $1,933